MarA, SoxS and Rob are transcription factors belonging to the AraC family. While these proteins have been associated historically with control of multiple antibiotic resistance, and tolerance to oxidative stress agents and organic solvents, only a paucity of experimental data support a role in regulating virulence. Clinical Escherichia coli isolates, and isogenic strains lacking marA, soxS and rob, were studied in a murine model of ascending pyelonephritis, which is a clinically relevant model of urinary tract infection. Organisms lacking all three transcription factors (triple knockouts) were significantly less virulent than parental strains, and complementation studies demonstrated that the addition of marA, soxS and rob individually restored wild-type virulence in the triple-knockout strain. Deletion of soxS or rob alone was more detrimental than the removal of marA. Thus, all three proteins contribute to virulence in vivo.
ArizaR. R,
LiZ,
RingstadN,
DempleB.
1995; Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein. J Bacteriol 177:1655–1661
Bahrani-MougeotF. K,
BucklesE. L,
LockatellC. V,
HebelJ. R,
JohnsonD. E,
TangC. M,
DonnenbergM. S.
2002; Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol 45:1079–1093[CrossRef]
BarbosaT. M,
LevyS. B.
2000; Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol 182:3467–3474[CrossRef]
BennikM. H,
PomposielloP. J,
ThorneD. F,
DempleB.
2000; Defining a rob regulon in Escherichia coli by using transposon mutagenesis. J Bacteriol 182:3794–3801[CrossRef]
BieberD,
RamerS. W,
WuC. Y,
MurrayW. J,
TobeT,
FernandezR,
SchoolnikG. K.
1998; Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli . Science 280:2114–2118[CrossRef]
BinaJ,
ZhuJ,
DziejmanM,
FaruqueS,
CalderwoodS,
MekalanosJ.
2003; ToxR regulon of Vibrio cholerae and its expression in vibrios shed by cholera patients. Proc Natl Acad Sci U S A 100:2801–2806[CrossRef]
BrzuszkiewiczE,
BruggemannH,
LiesegangH.
10 other authors2006; How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci U S A 103:12879–12884[CrossRef]
ChampionG. A,
NeelyM. N,
BrennanM. A,
DiRitaV. J.
1997; A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of toxT mutant strains. Mol Microbiol 23:323–331[CrossRef]
DattelbaumJ. D,
LockatellC. V,
JohnsonD. E,
MobleyH. L.
2003; UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections. Infect Immun 71:1026–1030[CrossRef]
ErikssonS,
LucchiniS,
ThompsonA,
RhenM,
HintonJ. C.
2003; Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica . Mol Microbiol 47:103–118
FetherstonJ. D,
BeardenS. W,
PerryR. D.
1996; YbtA, an AraC-type regulator of the Yersinia pestis pesticin/yersiniabactin receptor. Mol Microbiol 22:315–325[CrossRef]
FlashnerY,
MamroudE,
TidharA.
10 other authors2004; Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates. Infect Immun 72:908–915[CrossRef]
FrotaC. C,
PapavinasasundaramK. G,
DavisE. O,
ColstonM. J.
2004; The AraC family transcriptional regulator Rv1931c plays a role in the virulence of Mycobacterium tuberculosis . Infect Immun 72:5483–5486[CrossRef]
Garrity-RyanL,
KazmierczakB,
KowalR,
ComolliJ,
HauserA,
EngelJ. N.
2000; The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect Immun 68:7100–7113[CrossRef]
GeorgeA. M,
LevyS. B.
1983a; Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli : involvement of a non-plasmid-determined efflux of tetracycline. J Bacteriol 155:531–540
GeorgeA. M,
LevyS. B.
1983b; Gene in the major cotransduction gap of the Escherichia coli K-12 linkage map required for the expression of chromosomal resistance to tetracycline and other antibiotics. J Bacteriol 155:541–548
HauserA. R,
KangP. J,
EngelJ. N.
1998; PepA, a secreted protein of Pseudomonas aeruginosa , is necessary for cytotoxicity and virulence. Mol Microbiol 27:807–818[CrossRef]
HopkinsW. J,
HallJ. A,
ConwayB. P,
UehlingD. T.
1995; Induction of urinary tract infection by intraurethral inoculation with Escherichia coli : refining the murine model. J Infect Dis 171:462–465[CrossRef]
HungD. T,
ShakhnovichE. A,
PiersonE,
MekalanosJ. J.
2005; Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310:670–674[CrossRef]
HvidbergH,
StruveC,
KrogfeltK. A,
ChristensenN,
RasmussenS. N,
Frimodt-MollerN.
2000; Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother 44:156–163[CrossRef]
KerrnM. B,
Frimodt-MollerN,
EspersenF.
2003; Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model. Antimicrob Agents Chemother 47:1002–1009[CrossRef]
KolterR,
InuzukaM,
HelinskiD. R.
1978; Trans -complementation-dependent replication of a low molecular weight origin fragment from plasmid R6K. Cell 15:1199–1208[CrossRef]
KoutsolioutsouA,
MartinsE. A,
WhiteD. G,
LevyS. B,
DempleB.
2001; A soxRS -constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (serovar Typhimurium). Antimicrob Agents Chemother 45:38–43[CrossRef]
LindeH. J,
NotkaF,
MetzM,
KochanowskiB,
HeisigP,
LehnN.
2000; In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of marR . Antimicrob Agents Chemother 44:1865–1868[CrossRef]
LinkA. J,
PhillipsD,
ChurchG. M.
1997; Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli : application to open reading frame characterization. J Bacteriol 179:6228–6237
ManeewannakulK,
LevyS. B.
1996; Identification of mar mutants among quinolone-resistant clinical isolates of Escherichia coli . Antimicrob Agents Chemother 40:1695–1698
MartinR. G,
GilletteW. K,
RosnerJ. L.
2000; Promoter discrimination by the related transcriptional activators MarA and SoxS: differential regulation by differential binding. Mol Microbiol 35:623–634
OttoK,
NorbeckJ,
LarssonT,
KarlssonK. A,
HermanssonM.
2001; Adhesion of type 1-fimbriated Escherichia coli to abiotic surfaces leads to altered composition of outer membrane proteins. J Bacteriol 183:2445–2453[CrossRef]
RandallL. P,
WoodwardM. J.
2001; Role of the mar locus in virulence of Salmonella enterica serovar Typhimurium DT104 in chickens. J Med Microbiol 50:770–779
Rippere-LampeK. E,
O'BrienA. D,
ConranR,
LockmanH. A.
2001; Mutation of the gene encoding cytotoxic necrotizing factor type 1 [cnf(1)] attenuates the virulence of uropathogenic Escherichia coli . Infect Immun 69:3954–3964[CrossRef]
RuizJ,
SimonK,
HorcajadaJ. P.
8 other authors2002; Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol 40:4445–4449[CrossRef]
RussoT. A,
McFaddenC. D,
Carlino-MacDonaldU. B,
BeananJ. M,
BarnardT. J,
JohnsonJ. R.
2002; IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli . Infect Immun 70:7156–7160[CrossRef]
SchillingJ. D,
LorenzR. G,
HultgrenS. J.
2002; Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli . Infect Immun 70:7042–7049[CrossRef]
SchneidersT,
BarbosaT. M,
McMurryL. M,
LevyS. B.
2003; The Escherichia coli transcriptional regulator MarA directly represses transcription of purA and hdeA . J Biol Chem 279:9037–9042
SimonR,
PrieferU,
PuehlerA.
1983; A broad host range mobilizing system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Biotechnology 1:784–791[CrossRef]
SnyderJ. A,
HaugenB. J,
BucklesE. L,
LockatellC. V,
JohnsonD. E,
DonnenbergM. S,
WelchR. A,
MobleyH. L.
2004; Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 72:6373–6381[CrossRef]
SukupolviS,
O'ConnorC. D.
1990; TraT lipoprotein, a plasmid-specified mediator of interactions between Gram-negative bacteria and their environment. Microbiol Rev 54:331–341
SulavikM. C,
DazerM,
MillerP. F.
1997; The Salmonella typhimurium mar locus: molecular and genetic analyses and assessment of its requirement for virulence. J Bacteriol 179:1857–1866
TorresA. G,
RedfordP,
WelchR. A,
PayneS. M.
2001; TonB-dependent systems of uropathogenic Escherichia coli : aerobactin and heme transport and TonB are required for virulence in the mouse. Infect Immun 69:6179–6185[CrossRef]
van der StraatenT,
ZulianelloL,
GrangerD. L,
JanssenR,
van DiepenA,
van DisselJ. T.
2004; Salmonella enterica serovar Typhimurium RamA, intracellular oxidative stress response, and bacterial virulence. Infect Immun 72:996–1003[CrossRef]
WestphalO,
JannK.
1965; Bacterial lipopolysaccharides. Extraction with phenol–water and further applications of the procedure. Methods Carbohydr Chem 5:83–91
WolfgangM. C,
LeeV. T,
GilmoreM. E,
LoryS.
2003; Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway. Dev Cell 4:253–263[CrossRef]
WuJ,
WeissB.
1991; Two divergently transcribed genes, soxR and soxS , control a superoxide response regulon of Escherichia coli . J Bacteriol 173:2864–2871
YamamotoS,
TsukamotoT,
TeraiA,
KurazonoH,
TakedaY,
YoshidaO.
1995; Distribution of virulence factors in Escherichia coli isolated from urine of cystitis patients. Microbiol Immunol 39:401–404[CrossRef]